Cowen And Company, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$59.04 - $77.95 $437,486 - $577,609	-7,410 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $214,964 - $550,044	7,410 New	7,410 $542,000
Q1 2020 May 11, 2020	SELL	$27.51 - $57.29 $117,687 - $245,086	-4,278 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$40.86 - $57.65 $907,990 - $1.28 Million	-22,222 Reduced 83.86%	4,278 $233,000
Q3 2019 Nov 12, 2019	BUY	$37.38 - $49.47 $990,570 - $1.31 Million	26,500 New	26,500 $1.11 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.